Literature DB >> 25848513

Comparison of histopathological analysis, culture and polymerase chain reaction assays to detect mucormycosis in biopsy and blood specimens.

Parisa Badiee1, Amir Arastefar1, Hadis Jafarian1.   

Abstract

BACKGROUND AND OBJECTIVES: The aim of this study was to compare direct microscopic examination with culture and PCR for the diagnosis of Mucorales infection in blood and tissue specimens.
MATERIAL AND METHODS: Blood samples and tissue specimens were obtained from 28 patients (total 58 samples) with suspected invasive fungal infection and cultured on proper media. Direct smear of tissue samples was done with potassium hydroxide, hematoxylin and eosin, and methenamine silver staining. DNA extracted from blood and tissue specimens were used for semi-nested PCR targeting 18S rDNA of Mucorales species.
RESULTS: Mucormycosis was documented in 7/28 (25%) of tissue specimens with positive findings by direct smear, of which PCR and culture were positive in 6 (86%) and 5 (70%) specimens, respectively. The etiologic agents were Mucor spp. and Rhizopus spp. However, culture and PCR results for all blood specimens were negative.
CONCLUSIONS: As the orders of Mucorales do not have well growth in culture media, PCR with tissue specimens is more sensitive than tissue or blood culture methods. Unfortunately, there is no alternative method for direct smear, which is an invasive method. Molecular methods may be helpful in these cases.

Entities:  

Keywords:  18S rDNA; Invasive fungal infection; Mucoracea; Semi-nested PCR

Year:  2013        PMID: 25848513      PMCID: PMC4385169     

Source DB:  PubMed          Journal:  Iran J Microbiol        ISSN: 2008-3289


INTRODUCTION

Invasive fungal infection (IFI) is one of the main causes of mortality and morbidity among hematological malignancies and immunocompromised patients (1, 2). The most common fungi in such infections are Aspergillus and Candida species; however, a number of other organisms such as members of the Mucoracea are increasing frequently (3). Mucormycosis should be considered in transplant recipients and patients with hematological malignancies, renal failure and diabetes mellitus(4),and immunocompromised patients including those with HIV infection(5). In the past decades, the incidence of IFI has increased. Tiraboschi et al. reported incidence rates of mucor-mycosis of 0.13%, between 1980 and 2004 (10 cases), and 0.86% between 2005 and 2010 (7 cases)patient-years(6). In another report, 7% of patients at autopsy and 20 patients per 100 000 admissions were diagnosed with mucormycosis, and the mortality rate for these patients was about 50% to 100% (7). The highest incidence of mucormycosis (more than 90%) is related to Rhizopus spp., followed by Mucorspp.,Lichtheimia spp., and, rarely, some other species(8, 9). Given the high mortality rate and rapid progression, early diagnosis and effective treatment are important. There are many different methods for the diagnosis of IFI, such as considering signs and symptoms,serologic tests, culturing and microscopic examination, imaging procedures, histopathological methods, and polymerase chain reaction (PCR) (10-12). The documented diagnosis of IFI by mold fungi requires either the presence of hyphae in the involved tissues or growth of the fungus from sterile tissue in plate cultures (3). The diagnosis of mucormycosis is more difficult than other fungal infections, and its treatment is challenging because under normal laboratory conditions, sporulation fails and culture results from the biopsies are often negative due to unviable organism in necrotic tissues(13).Moreover, morphological identification of the hyphae can not help distinguish between different fungal species (14, 15). Although culture is considered the gold standard for determining the causative agent, observing Mucor-like hyphae in the involved tissues by histopathologic examination can also establish mucormycosis (16). No serological test is available, radiological methods are not specific and very few studies have used molecular techniques such as PCR to detect this infection. Given very few studies on molecular method of mucormycosis diagnosis, in this study, we evaluated the semi-nested PCR method for the detection of zygomycete fungi in blood and tissue specimens, and compared it with direct smear as the gold standard.

MATERIALS AND METHODS

During two years (2010–2011), 28 patients with suspected IFI and for whom blood and tissue specimens were available, were enrolled in this study. Suspected IFI was defined as fever that developed or progressed during broad-spectrum antibacterial therapy after 96 hours, or radiological symptoms including focal lung lesions with or without surrounding halo, opacification of the sinuses as detected by high-resolution computed tomography, or typical endobronchial lesions detected by bronchoscopy, major peripheral embolization in echocardiography,especially in patients undergoing lung transplantation or those receiving mechanical ventilation, and heart failure.Biopsy specimens were carefully divided by cutting with a knife. Equal parts were used for histopathological analysis, culture, and molecular testing by examiners who were unaware of the microbiological, histopathological and clinical data. Blood samples were cultured on BACTEC medium (Becton-Dickinson, Sparks, MD, USA) and tissue cultures from sinus, heart (infected valve or vegetation) and lung were cultured on Sabourauddextrose agar (Merck,Darmstadt, Germany). Direct smear of tissue samples was done with hematoxylin and eosin staining and methenamine silver staining for histopathological examination, and with potassium hydroxide in the mycology lab for the detection of hyphae in the tissues. The hyphae of zygomycetes appeared as wide, ribbon-like, pauci septate hyphae with right-angle branching, as described in the literature(17). Each tissue sample (transported in saline) was grown on three plates of Sabouraud dextrose agar and incubated at 30 °C for 21 days. The result was considered positive if two out of three plates grew the same isolated fungi. Genus determination of the fungus was done by direct smear with lactophenol cotton blue. DNA was extracted from the sera and tissues with QIAmp DNA Minikit (Qiagen, Hilden, Germany) in accordance with the manufacturer’s recommendations. Extracted DNA concentrations were determined with a NanoDropND-1000 UV/Visspectrophotometer (NanoDrop, USA). The PCR program, master mix making, and primers of 18S rDNA from Mucorales were based on Rickertset al. (18). These primers were divided into two groups: ZM1(5′-ATT ACC ATG AGC AAA TCA GA-3′) and ZM2 (5′-TCC GTC AAT TCC TTT AAG TTT C-3′) for amplification of a 407-408 bp fragment (for the first round of PCR), and ZM1 and ZM3(5′-CAA TCC AAG AAT TTC ACC TCT AG-3′) for amplification of a 176-177 bp fragment (for the second round of PCR). All primers were made by Bioneer (South Korea). The PCR products were separated by2% agarose gel electrophoresis (voltage 70, 1 hour), stained with ethidium bromide, and visualized with the Gel doc system (Gel Logic 2000, Kodak, USA). To determine the lowest detection limit of PCR, different concentrations of the DNA extracted from Mucor isolates were subjected to PCR (extracted DNAs were diluted for 4, 2, 1, 0.5, and 0.25 ng/μL) (Fig. 1). Positive and negative controls for each PCR set were included.
Fig. 1

Serial dilutions of DNA extracted from clinically isolated Mucor species. The first lane is the 100-bp DNA size marker. The lower limit of detection of the PCR assay was 0.25 ng/μL extracted DNA with 176 base pairs.

Statistical analysis was performed with SPSS software for Windows (Statistical Package for Social Sciences,version 15.0, SPSS Inc, Chicago, IL, USA).This research study conformed to the Helsinki Declaration and local legislation, and was approved by the local ethics committee.

RESULTS

Of the28 patients suspected to have IFIs, non septatedhyphae were detected histopathologically in 7 (25%) tissue samples. Their median age was 47 years (range, 11–75 years) and the females tomales ratio was 8/20. According to the criteria of the European Organization for Research and Treatment of Cancer/Mycoses Study Group of the National Institute of Allergy and Infectious Diseases (3), all 7 patients had proven mucormycosis. None of the blood cultures was positive, and no false positives were detected in the tissue cultures. Tissue cultures from 5 patients were positive for the etiological agent Rhizopousspp. in 4 cases and Mucorspp. in 1 case. All positive samples were from sinuses. The lower limit of PCR detection was 0.25 ng of DNA (Fig. 1). The PCR test results for all serum samples (28 sera) were negative. For the tissue specimens, 7 positive findings on direct smear but 6 were positive with PCR (Table 1) The PCR results were negative in all samples with negative culture results except for 1 case, from which C. albicans was isolated.
Table 1

Results of different methods in patients with mucormycosis.

No.Sex/ age (years)Tissue smearTissue cultureBlood culturePCR BloodPCR TissueOutcome
1Female/11Non septated hyphae---+Survived
2Male/66Nonseptated hyphae+---Died
3Female/67Non septated hyphae---+Survived
4Male/51Non septated hyphae+--+Survived
5Female/75Non septated hyphae+--+Died
6Female/19Non septated hyphae+--+Survived
7Male/31Non septated hyphae+--+Survived
In this study, direct smear was considered the gold standard (16). Compare with the gold standard test, the sensitivity, specificity, positive and negative predictive value was 70%, 100%, 100% and 91% for tissue culture and 86%, 96%, 86% and 96% for tissue PCR.Table 1 presented the Results of different methods in patients with mucormycosis. Once the specimens arrived at the lab, the required tests were performed on them promptly and the results were sent to the clinicians. That’s why the mortality rate (2/7; 28.6%) was low due to early diagnosis.

DISCUSSION

In this study, we were able to increase the rate of etiologic diagnosis from 70% by culture method to 86% by PCR assay in patients with proven invasive mucormycosis. A confirmed diagnosis of mucormycosis requires the presence of characteristic hyphae in the involved tissues or other specimens by histopathologic staining or direct smear with potassium hydroxide (19). The presence of septated hyphae in the histopathology smear may mistakenly lead the pathologist to rule out zygomycosis, whose diagnosis requires professional pathological expertise, since it was previously thought that zygomycete hyphae are aseptate rather than pauciseptate.The presence of necrosis or fragmentation, and poor staining of thin hyphal walls, can make microscopic visualization difficult (20). Fungal culture is necessary to identify the genus. However, the recovery of zygomycetes can be difficult in culture (13, 19). Our results show that the sensitivity for tissue culture was 70% and blood culture specimens were all negative. Blood and urine cultures are rarely positive for zygomycetes (19), and the rates of successful tissue culture forhistopathologically positive smears were reported as 33% and 50% (21, 22). The negative results for specimen culture may be due to: A) The initial processing of hyphal elements by grinding, which may damage the large, pauciseptate hyphae and make them nonviable (21, 22), B) The presence of hyphal elements in only a small portion of the specimens (23), C) Prolonged antifungal pretreatment, or D) Suboptimal standard culture conditions for the recovery of this organism from necrotic tissues (23). In the present study, morphological examination was the gold standard because it yielded the highest rate of diagnosis of the infection. The diagnosis of animal molds from tissue specimens by PCR is more reliable than by culture (24). Our semi-nested PCR method in tissue samples had a sensitivity of 86% and a specificity of 96%and none of the blood samples was positive for mucormycosis. The sensitivity of real-time PCR in tissues for detecting Mucorales was reported to be 100%(25), in 2 tissue samples; however, the limited number of samples compromises the accuracy of this result. In contrast, the sensitivity in formalin-fixed and paraffin-embedded tissues was reported to be 57% (25). It is likely that extensive cross-linking of tissue proteins after fixation in formaldehyde increased fragmentation of the nucleic acids and inhibited the PCR process (26). Freshness of the tissue specimens is thus critical for the accuracy of PCR assays. In conclusion,new molecular and antigenic tools are required for the early detection of mucormycosis and therapeutic monitoring. For an accurate and dependable diagnosis of this infection, PCR in fresh tissue samples is more sensitive than tissue or blood culture methods. Unfortunately, there is no alternative method for examination by tissue direct smear, which is an invasive procedure.
  23 in total

1.  Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients.

Authors:  Kieren A Marr; Rachel A Carter; Fulvio Crippa; Anna Wald; Lawrence Corey
Journal:  Clin Infect Dis       Date:  2002-02-26       Impact factor: 9.079

2.  Molecular assay to detect nosocomial fungal infections in intensive care units.

Authors:  Parisa Badiee; Abdolvahab Alborzi; Mehrvash Joukar
Journal:  Eur J Intern Med       Date:  2011-09-16       Impact factor: 4.487

3.  Detection of Aspergillus species in bone marrow transplant patients.

Authors:  Parisa Badiee; Abdolvahab Alborzi
Journal:  J Infect Dev Ctries       Date:  2010-09-03       Impact factor: 0.968

Review 4.  Zygomycosis: the re-emerging fungal infection.

Authors:  M Chayakulkeeree; M A Ghannoum; J R Perfect
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2006-04       Impact factor: 3.267

5.  Epidemiology of nosocomial fungal infections.

Authors:  S K Fridkin; W R Jarvis
Journal:  Clin Microbiol Rev       Date:  1996-10       Impact factor: 26.132

6.  Diagnostic potential of nested PCR, galactomannan EIA, and beta-D-glucan for invasive aspergillosis in pediatric patients.

Authors:  Parisa Badiee; Abdolvahab Alborzi; Mahammad Karimi; Bahman Pourabbas; Pedram Haddadi; Jalal Mardaneh; Mahsa Moieni
Journal:  J Infect Dev Ctries       Date:  2012-04-13       Impact factor: 0.968

7.  Aspergillus hyphae in infected tissue: evidence of physiologic adaptation and effect on culture recovery.

Authors:  Jeffrey J Tarrand; Xiang Y Han; Dimitrios P Kontoyiannis; Gregory S May
Journal:  J Clin Microbiol       Date:  2005-01       Impact factor: 5.948

Review 8.  Zygomycetes in human disease.

Authors:  J A Ribes; C L Vanover-Sams; D J Baker
Journal:  Clin Microbiol Rev       Date:  2000-04       Impact factor: 26.132

Review 9.  Zygomycosis.

Authors:  Corina E Gonzalez; Michael G Rinaldi; Alan M Sugar
Journal:  Infect Dis Clin North Am       Date:  2002-12       Impact factor: 5.982

10.  Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group.

Authors:  Ben De Pauw; Thomas J Walsh; J Peter Donnelly; David A Stevens; John E Edwards; Thierry Calandra; Peter G Pappas; Johan Maertens; Olivier Lortholary; Carol A Kauffman; David W Denning; Thomas F Patterson; Georg Maschmeyer; Jacques Bille; William E Dismukes; Raoul Herbrecht; William W Hope; Christopher C Kibbler; Bart Jan Kullberg; Kieren A Marr; Patricia Muñoz; Frank C Odds; John R Perfect; Angela Restrepo; Markus Ruhnke; Brahm H Segal; Jack D Sobel; Tania C Sorrell; Claudio Viscoli; John R Wingard; Theoklis Zaoutis; John E Bennett
Journal:  Clin Infect Dis       Date:  2008-06-15       Impact factor: 9.079

View more
  9 in total

1.  Sinonasal Mucormycosis: A to Z.

Authors:  V P Singh; Chetan Bansal; Madhuri Kaintura
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2018-05-04

2.  Disseminated mucormycosis: An unusual case of ascites with bone marrow invasion.

Authors:  Chowdhury Adnan Sami; Hasan Mostafa Rashed; Abed Hussain Khan; Lovely Barai; Shohael Mahmud Arafat
Journal:  IDCases       Date:  2022-07-04

3.  Comparison of serum PCR assay and histopathology for the diagnosis of invasive aspergillosis and mucormycosis in immunocompromised patients with sinus involvement.

Authors:  S Shokouhi; J Mirzaei; M M Sajadi; A Javadi
Journal:  Curr Med Mycol       Date:  2016-12

4.  Mucormycosis: an unusual masquerader of an endobronchial tumour.

Authors:  Venugopal Jaganathan; Vijaya Prakash Madesh; Santhakumar Subramanian; Rajeshwari K Muthusamy; Sangita S Mehta
Journal:  Respirol Case Rep       Date:  2019-09-30

5.  Orbital Apex Syndrome due to Orbital Mucormycosis after Teeth Infection: A Successful Case Report.

Authors:  Gonçalo Godinho; Isabel Abreu; Gonçalo Alves; Ricardo Vaz; Vitor Leal; Ana Cláudia Carvalho; António Sarmento; Fernando Falcão-Reis
Journal:  Case Rep Ophthalmol       Date:  2021-04-08

Review 6.  Fungal Genomics in Respiratory Medicine: What, How and When?

Authors:  Amelie P Brackin; Sam J Hemmings; Matthew C Fisher; Johanna Rhodes
Journal:  Mycopathologia       Date:  2021-09-07       Impact factor: 2.574

7.  Evaluation of Direct Examination, Culture, and Histopathology in the Diagnosis of Mucormycosis: Reiterating the Role of KOH Mount for Early Diagnosis.

Authors:  Aroop Mohanty; Pratima Gupta; Kunnumbrath Arathi; Shalinee Rao; Ranjana Rohilla; Suneeta Meena; Ashok Singh; Neelam Kaistha; Rama S Rath; Saurabh Varshney
Journal:  Cureus       Date:  2021-11-10

8.  Diagnosis of oesophageal mucormycosis managed with medical therapy alone.

Authors:  Matthew Ringer; Lauren Pischel; Marwan Mikheal Azar
Journal:  BMJ Case Rep       Date:  2020-10-22

9.  Evaluation of nested PCR in diagnosis of fungal rhinosinusitis.

Authors:  Parisa Badiee; Behrooz Gandomi; Gholamabbass Sabz; Bijan Khodami; Maral Choopanizadeh; Hadis Jafarian
Journal:  Iran J Microbiol       Date:  2015-02
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.